viewCello Health PLC

Cello Health sells social media analytics software business for £4.5mln

The sum will be paid through shares, with Cello receiving an 11.3% stake in the UK-based software provider

Cello Health PLC - Cello Health sells social media analytics software business for £4.5mln
Pulsar has gross assets of £3.2mln

Cello Health PLC (LON:CLL) has sold social media analytics business Pulsar to Access Intelligence PLC (LON:ACC) in exchange for £4.5mln worth of shares.

After the completion, Cello will own an 11.3% stake in the UK-based software provider.

READ:Cello Health grows interim profits and eyes further acquisitions

Pulsar, which has gross assets of £3.2mln, will still work for Cello in cases of “mutual client opportunity”.

The AIM-listed health advisory group said the sale would enable it to concentrate investment in the expanding healthcare section as well as Signal, its marketing services division.

“Post the exit of Facebook in 2017 as a data provider, general growth in this social media analytics market has been slower,” Cello said in a statement.

Mark Scott, chief executive of Cello, commented: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."

Shares were flat at 127.06p at noon.

Quick facts: Cello Health PLC

Price: 131.5 GBX

Market: AIM
Market Cap: £139.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...



Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19


Total Voting Rights

1 week, 4 days ago

Holding(s) in Company

3 weeks, 1 day ago

Holding(s) in Company

1 month ago

Total Voting Rights

1 month, 1 day ago

Total Voting Rights

on 7/10/19


on 2/10/19

Interim Results

on 18/9/19

2 min read